Europe is emerging as an attractive route to global market access for Chinese sponsors. Early consideration of EMA requirements can help avoid costly delays and improve approval success. Read the article: https://ow.ly...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Data Science: transforming the future of clinical trials
Gerard Quinn, VP of IT Innovation & Informatics, offers insights on the use of Machine Learning and Artificial Intelligence in clinical trials, and the potential benefits and challenges for CROs and sponsors (pages 16-17).
-
AI in Life Sciences – Covid pushes AI driven clinical trials and drug manufacturing into the limelight
ICON’s CIO, Tom Leary discusses the challenges to patient recruitment during the COVID pandemic and how big data, combined with advanced AI algorithms processing has the potential to reduce trial costs.
-
Role of data in revolutionising the CRO industry
In a wide-ranging interview with PharmaBoardroom, ICON CIO, Tom O’Leary highlights the role of data in revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes.
-
Keeping it Real: Challenges and Benefits of Integrating AI and Machine Learning into Pharma R&D
ICON's CIO Tom O'Leary provides expert commentary on integrating AI and machine learning into Pharma R&D in this January 2020 Bio IT World Article.
